[{"_id":"5641e8f7fd1ef1594b89c8d7","決算期":"2014年3月期","証券コード":"4272","会社名":"日本化薬(株)【4272】","会計方式":"日本方式","決算発表日":"2014年5月8日","決算月数":"12か月","売上高":"160,080百万円","営業利益":"24,090百万円","経常利益":"26,496百万円","当期利益":"16,718百万円","EPS（一株当たり利益）":"92.25円","調整一株当たり利益":"92.25円","BPS（一株当たり純資産）":"918.35円","総資産":"247,592百万円","自己資本":"166,421百万円","資本金":"14,932百万円","有利子負債":"21,281百万円","自己資本比率":"67.2%","ROA（総資産利益率）":"7.08%","ROE（自己資本利益率）":"10.56%","総資産経常利益率":"11.22%","日付":"2015-11-10T12:55:42.751Z"},{"_id":"5641e8f7fd1ef1594b89c8d8","決算期":"2015年3月期","証券コード":"4272","会社名":"日本化薬(株)【4272】","会計方式":"日本方式","決算発表日":"2015年5月11日","決算月数":"12か月","売上高":"161,861百万円","営業利益":"22,301百万円","経常利益":"25,162百万円","当期利益":"15,653百万円","EPS（一株当たり利益）":"86.38円","調整一株当たり利益":"86.31円","BPS（一株当たり純資産）":"1,030.16円","総資産":"265,126百万円","自己資本":"186,659百万円","資本金":"14,932百万円","有利子負債":"14,927百万円","自己資本比率":"70.4%","ROA（総資産利益率）":"6.11%","ROE（自己資本利益率）":"8.87%","総資産経常利益率":"9.82%","日付":"2015-11-10T12:55:42.751Z"},{"_id":"5641e8f7fd1ef1594b89c8d9","決算期":"2013年3月期","証券コード":"4272","会社名":"日本化薬(株)【4272】","会計方式":"日本方式","決算発表日":"2013年5月9日","決算月数":"10か月","売上高":"128,104百万円","営業利益":"17,066百万円","経常利益":"20,480百万円","当期利益":"12,342百万円","EPS（一株当たり利益）":"68.09円","調整一株当たり利益":"68.06円","BPS（一株当たり純資産）":"828.87円","総資産":"224,705百万円","自己資本":"150,238百万円","資本金":"14,932百万円","有利子負債":"16,308百万円","自己資本比率":"66.9%","ROA（総資産利益率）":"---","ROE（自己資本利益率）":"---","総資産経常利益率":"---","日付":"2015-11-10T12:55:42.751Z"}]